Default company panoramic image
Dfee97a0 5483 4c20 962d 34f4491f4751

NovoVia, Inc.

NovoVia aims to cure infertility due to ovarian or testicular failure using eggs or sperm derived from an individual's stem cells.

  • Stage Not Set
  • Industry Biotechnology
  • Location New York City, NY, USA
  • Currency USD
  • Founded June 2013
  • Employees 4

Company Summary

NovoVia brings together some of the leading researchers in the field of infertility - led by Renee Reijo Pera (Director of Human Pluripotent Stem Cell Research at Stanford) - capable of translating the latest, ground-breaking research in infertility (including their own) into clinical practice in 2-3 years. Its mission is to allow all people the possibility of genetic offspring - notably, those not helped by IVF and other current forms of ART.


  • Default avatar
    Renee Reijo Pera

    Co-founder; PhD; George D Smith Professor of Stem Cell Biology & Regenerative Medicine, Stanford University; Director, Human Pluripotent Stem Cell Research & Education, Stanford University

  • Default avatar
    Carlos Simon

    Co-founder; MD, PhD; Professor of Obstetrics & Gynecology, University of Valencia (Spain); Scientific Director, IVI Foundation (Spain; one of the largest IVF centers in the world); Adjunct Clinical Professor, Stanford University School of Medicine (U.S.A.)

  • Default avatar
    Kyle Orwig

    Co-founder; PhD; Associate Professor of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh; Director, Fertility Preservation Program, Magee-Women's Research Institute (Pittsburgh)

  • Default avatar
    Joseph Gottfried

    Co-founder, President & Secretary of NovoVia; MD, JD; Board-certified internist; Formerly, McKinsey & Company (New York), McKinsey Hospital Institute (London)


  • Default avatar
    Stephen B. Thau (Morrison & Foerster, Corporate Counsel); Terri Shieh-Newton (Morrison & Foerster, Patent Counsel)